The role of external evidence in data monitoring of a clinical trial

Statistics in Medicine

Volumn 15, Issue 12, 1996, Pages 1285-1293

  Pocock, Stuart J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DECISION MAKING; META ANALYSIS; MONITORING; RANDOMIZED CONTROLLED TRIAL;

EID: 8944237520     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960630)15:12<1285::AID-SIM309>3.0.CO;2-0     Document Type: Conference Paper

References (18)

1. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. 'The early termination of clinical trials: causes, consequences and control', European Heart Journal, 15, 721-738 (1994).
2. Pocock, S. J. 'When to stop a clinical trial', British Medical Journal, 305, 235-244 (1992).
3. Fleming, T. R. and Watelat, L. F. 'Approaches to monitoring clinical trials', Journal of the National Cancer Institute, 81, 188-193 (1989).
4. Geller, N. L. and Pocock, S. J. 'Interim analyses in randomized clinical trials', Biometrics, 43, 213-223 (1987).
5. Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F. and Chalmers, T. C. 'Cumulative meta-analysis of therapeutic trials for myocardial infarction', New England Journal of Medicine, 327, 248-254 (1992).
6. Thompson, S. G. and Pocock, S. J. 'Can meta-analyses be trusted?', Lancet, 338, 1127-1130 (1992).
7. Mulrow, C. D. 'Rationale for systematic reviews', British Medical Journal, 309, 597-599 (1994).
8. Eysenck, H. J. 'Meta analysis and its problems', British Medical Journal, 309, 789-792 (1994).
9. Rothman, K. J. and Michels, K. B. 'The continuing unethical use of placebo controls', New England Journal of Medicine, 331, 394-398 (1994).
10. de Lorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J-L., Monjaud, I., Guidollet, J., Touboul, P. and Delaye, J. 'Mediterranean alpha-linoleic acid-rich diet in secondary prevention of coronary heart disease', Lancet, 343, 1454-1459 (1994).
11. Doval, H. C., Nul, D. R., Grancelli, H. O., Perrone, V. S., Bortman, G. R. and Curiel, R. 'Randomized trial of low-dose amiodarone in severe congestive heart failure', Lancet, 344, 493-498 (1994).
12. ISIS-4 Collaborative Group. 'Fourth international study of infarct survival: protocol for a large simple study of the effects of oral mononitrate, of oral captopril and of oral magnesium', American Journal of Cardiology, 68, 87D-100D (1991).
13. MRC Vitamin Study Research Group. 'Prevention of neural tube defects: results of the MRC Vitamin Study', Lancet, 338, 131-137 (1991).
14. Laurence, K. M., James, N., Miller, M. H., Tennant, G. B. and Campbell, H. 'Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects', British Medical Journal, 282, 1509-1511 (1981).
15. Czeizel, A. and Fritz, G. 'Ethics of a randomized trial of periconceptual vitamins', Journal of the American Medical Association, 262, 1633-1634 (1989).
16. ISIS-4 Collaborative Group. 'A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction', Lancet, 345, 669-685 (1995).
17. ISIS-4 Collaborative Group. 'Magnesium in acute myocardial infarction', British Medical Journal, 310, 751-752 (1995).
18. Egger, M. and Smith, G. D. 'Misleading meta-analysis', British Medical Journal, 752-754 (1995).